of Vice President-Business Development at Torrey Pines Bank. David Milich, Ph.D. (Director, Founder and CEO): Dr. Milich is a world-renowned immunologist with extensive experience... asset for VLP's clinical development programs. Dr. Milich is also President and CEO of VRISD. Prior to starting VLP Biotech, Dr. Milich also co-founded Immune Complex Corporation... held business development positions at several leading biopharmaceutical manufacturing organizations including Lonza and Diosynth. He most recently served as Head of Sales...

already demonstrated protection in animal models. Pre-clinical development continues with the intent to begin a Phase I clinical trial in early 2010. HCV A panel of VLPs in pre...-clinical development that target consensus epitopes from the E2 protein of hepatitis C virus (HCV) raise high titer antibodies. Furthermore, a single epitope has shown potent cross...

orphan drug status for these products and expedite their clinical development. In the long-term, the flexibility of our carrier technology and our strong relationship with VRISD...